Literature DB >> 1794430

The influence of drop size on pupil dilatation.

R H Gray1.   

Abstract

The clinical efficacy of reduced size dilating drops (micro drops), was assessed in 60 patients. For each patient, one eye received the standard 'minim' drop size (26 microliters) while the fellow eye received a micro drop of five microliters. In 20 patients tropicamide 1% was followed after two minutes by phenylephrine 10%, another 20 patients were given tropicamide 1% alone, and for the last 20 patients, 0.5% tropicamide was used. Satisfactory mydriasis was achieved for all pupils except those receiving micro drops of tropicamide 0.5% (25 micrograms tropicamide). Tropicamide 1% in micro drop formulation (50 micrograms tropicamide) gave almost identical mydriasis to that from standard drops (containing 250 micrograms tropicamide). Tropicamide 1% in combination with phenylephrine 10% was superior to tropicamide 1% alone, after standard or micro drop administration. The micro drops used in this study were effective, easy to administer, and caused less patient discomfort.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1794430     DOI: 10.1038/eye.1991.107

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  4 in total

1.  Design, pharmacokinetic, and pharmacodynamic evaluation of a new class of soft anticholinergics.

Authors:  Fenglei Huang; Clinton E Browne; Whei-Mei Wu; Attila Juhász; Fubao Ji; Nicholas Bodor
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

2.  Reduction in mydriatic drop size in premature infants.

Authors:  S Wheatcroft; A Sharma; J McAllister
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

3.  Short-term Analysis of the Residual Volume of an Eye Drop Following 23-Gauge Microincision Vitrectomy Surgery.

Authors:  Yong Koo Kang; Jong Chan Im; Jae Pil Shin; In Taek Kim; Dong Ho Park
Journal:  Korean J Ophthalmol       Date:  2017-07-06

4.  Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose.

Authors:  Louis R Pasquale; Shan Lin; Robert N Weinreb; James C Tsai; Robert L Kramm; Tsontcho Ianchulev
Journal:  Clin Ophthalmol       Date:  2018-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.